Health ❯Therapeutics

Targeted Therapies

Synthetic Binding Agents

Fibroblast ACSL4 Drives Ferroptosis and Offers New IBD Treatment Path

Linking lipid metabolism with iron-dependent epithelial cell death in gut fibroblasts reveals a targeted alternative to failed antioxidant therapies.

EPFL’s MEDUSA Technique Yields Aptamers With Up to 1,000-Fold Stronger Viral Binding